Fabrication,quality assurance,and assessment of cultured skin substitutes for treatment of skin wounds

摘要

Advances in treatment of skin wounds depend on demonstration of reduced morbidity or mortality either during or after hospitalization.Tissue engineering of skin grafts from cultured cells and biopolymers permits greater amounts of grafts from less donor tissue than conventional procedures.Autologous keratinocytes and fibroblasts isolated from epidermis and dermis of skin may be combined with collagen-based substrates to generate cultured skin substitutes (CSS) with epidermal and dermal components.By regulation of culture conditions,CSS form epidermal barrier and basement membrane,and release angiogenic factors that stimulate vascularization.Prototypes of CSS may be tested for safety and efficacy by grafting to athymic mice which do not reject human tissues.Clinical application of CSS requires establishment of quality assurance assessments,such as,epidermal barrier by measurement of surface hydration,and anatomy by standard histology.Medical benefits of tissue engineered skin for treatment of burns are evaluated quantitatively by the ratio of healed skin to donor skin,and qualitatively by the Vancouver Scar Scale.These benefits may also be extended to other medical conditions including chronic wounds and reconstructive surgery.